{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:45:40Z","timestamp":1745905540346},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jcv.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,2,11]],"date-time":"2018-02-11T15:16:16Z","timestamp":1518362176000},"page":"1-6","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2"],"prefix":"10.1016","volume":"102","author":[{"given":"Ramona","family":"Trebbien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Bohn","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thea K\u00f8lsen","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcv.2018.02.005_bib0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcv.2010.10.007","article-title":"Resistance and virulence mutations in patients with persistent infection by pandemic 2009A\/H1N1 influenza","volume":"50","author":"Alonso","year":"2011","journal-title":"J. Clin. Virol."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.005_bib0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcv.2014.07.004","article-title":"Prolonged shedding of pandemic influenza A (H1N1) 2009 virus in a pancreas-after-kidney transplant recipient","volume":"61","author":"Bruminhent","year":"2014","journal-title":"J. Clin. Virol."},{"issue":"10","key":"10.1016\/j.jcv.2018.02.005_bib0015","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/598684","article-title":"Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses","volume":"199","author":"Gooskens","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jcv.2018.02.005_bib0020","doi-asserted-by":"crossref","first-page":"e37095","DOI":"10.1371\/journal.pone.0037095","article-title":"I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y","volume":"7","author":"LeGoff","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2018.02.005_bib0025","unstructured":"World Health Organization. Influenza Vaccines. Available at: http:\/\/www.who.int\/influenza\/vaccines\/en\/ (Accessed 29 May 2017)."},{"key":"10.1016\/j.jcv.2018.02.005_bib0030","unstructured":"World Health Organization. Recommended Composition of Influenza Virus Vaccines for Use in the 2014-5 Northern Hemisphere Influenza Season. Available at: http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/201402_recommendation.pdf?ua=1 (Accessed 29 May 2017)."},{"issue":"9","key":"10.1016\/j.jcv.2018.02.005_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11908-014-0420-2","article-title":"Changing face of vaccination in immunocompromised hosts","volume":"16","author":"O\u2019Shea","year":"2014","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.005_bib0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/imt.13.171","article-title":"Influenza vaccination in immunocompromised patients: efficacy and safety","volume":"6","author":"Zbinden","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jcv.2018.02.005_bib0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/irv.12170","article-title":"Influenza prevention and treatment in transplant recipients and immunocompromised hosts","volume":"7","author":"Ison","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.jcv.2018.02.005_bib0050","article-title":"Influenza vaccines in immunosuppressed adults with cancer","volume":"10","author":"Eliakim-Raz","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jcv.2018.02.005_bib0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/irv.12084","article-title":"Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis","volume":"7","author":"Beck","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"issue":"5","key":"10.1016\/j.jcv.2018.02.005_bib0060","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0953-6205(01)00149-2","article-title":"Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients","volume":"12","author":"van der Velden","year":"2001","journal-title":"Eur. J. Intern. Med."},{"issue":"9492","key":"10.1016\/j.jcv.2018.02.005_bib0065","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jcv.2018.02.005_bib0070","doi-asserted-by":"crossref","first-page":"e0119115","DOI":"10.1371\/journal.pone.0119115","article-title":"Adamantane-resistant influenza a viruses in the world (1902\u20132013): frequency and distribution of M2 gene mutations","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS One"},{"issue":"0","key":"10.1016\/j.jcv.2018.02.005_bib0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"issue":"1 Pt B","key":"10.1016\/j.jcv.2018.02.005_bib0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"Nguyen","year":"2012","journal-title":"Antivir. Ther."},{"issue":"1","key":"10.1016\/j.jcv.2018.02.005_bib0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jcv.2013.01.009","article-title":"Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe","volume":"57","author":"Pozo","year":"2013","journal-title":"J. Clin. Virol."},{"issue":"3","key":"10.1016\/j.jcv.2018.02.005_bib0090","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.3.30445","article-title":"Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014","volume":"22","author":"Trebbien","year":"2017","journal-title":"Euro Surveill."},{"issue":"19","key":"10.1016\/j.jcv.2018.02.005_bib0095","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1128\/JVI.01109-09","article-title":"Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses","volume":"83","author":"Zhou","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.02.005_bib0100","series-title":"Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza","author":"World Health Organization Global Influenza Surveillance Network","year":"2011"},{"issue":"39","key":"10.1016\/j.jcv.2018.02.005_bib0105","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility \u2013 Geneva, November 2011 and June 2012","author":"World Health Organization","year":"2012","journal-title":"Wkly. Epidemiol. Rec."},{"issue":"9","key":"10.1016\/j.jcv.2018.02.005_bib0110","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/651610","article-title":"Rapid selection of a transmissible multidrug-resistant influenza A\/H3N2 virus in an immunocompromised host","volume":"201","author":"Memoli","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.005_bib0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1086\/595736","article-title":"A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A\/H3N2 virus","volume":"199","author":"Abed","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jcv.2018.02.005_bib0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jcv.2013.06.003","article-title":"Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011\u20132012 influenza season in Italy","volume":"58","author":"Piralla","year":"2013","journal-title":"J. Clin. Virol."},{"issue":"12","key":"10.1016\/j.jcv.2018.02.005_bib0125","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/508777","article-title":"Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child","volume":"43","author":"Baz","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.jcv.2018.02.005_bib0130","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1128\/AAC.03667-14","article-title":"Multiple influenza a (H3N2) mutations conferring resistance to neuraminidase inhibitors in a bone marrow transplant recipient","volume":"58","author":"Eshaghi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.005_bib0135","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02464-14","article-title":"Intrahost dynamics of antiviral resistance in influenza a virus reflect complex patterns of segment linkage, reassortment, and natural selection","volume":"6","author":"Rogers","year":"2015","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.jcv.2018.02.005_bib0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1086\/595736","article-title":"A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A\/H3N2 virus","volume":"199","author":"Abed","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jcv.2018.02.005_bib0145","doi-asserted-by":"crossref","first-page":"e32807","DOI":"10.1371\/journal.pone.0032807","article-title":"Genetic variability of human respiratory syncytial virus a strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication","volume":"7","author":"Eshaghi","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jcv.2018.02.005_bib0150","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/AAC.49.10.4075-4084.2005","article-title":"Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility","volume":"49","author":"Yen","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.jcv.2018.02.005_bib0155","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cmi.2016.07.007","article-title":"Functional balance between neuraminidase and haemagglutinin in influenza viruses","volume":"22","author":"Gaymard","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2018.02.005_bib0160","first-page":"103","article-title":"Defective-interfering (DI) RNAs of influenza viruses: origin, structure, expression, and interference","volume":"114","author":"Nayak","year":"1985","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"21","key":"10.1016\/j.jcv.2018.02.005_bib0165","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1007\/s00253-014-5933-y","article-title":"Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production","volume":"98","author":"Frensing","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"14","key":"10.1016\/j.jcv.2018.02.005_bib0170","doi-asserted-by":"crossref","first-page":"8064","DOI":"10.1128\/JVI.00240-13","article-title":"Sequence analysis of In vivo defective interfering-like RNA of influenza a H1N1 pandemic virus","volume":"87","author":"Saira","year":"2013","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.jcv.2018.02.005_bib0175","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1128\/JVI.72.7.5493-5501.1998","article-title":"Influenza virus nucleoprotein interacts with influenza virus polymerase proteins","volume":"72","author":"Biswas","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.02.005_bib0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virusres.2017.01.013","article-title":"Structural insights into RNA synthesis by the influenza virus transcription-replication machine","volume":"234","author":"Pflug","year":"2017","journal-title":"Virus Res."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218300386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218300386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T01:34:29Z","timestamp":1603848869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653218300386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":36,"alternative-id":["S1386653218300386"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2018.02.005","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}